PYRAZOLO[3,4-b]PYRIDINE AND PYRROLO[2,3-b]PYRIDINE INHIBITORS OF BRUTON'S TYROSINE KINASE
WO2017205769A1
Inhibitors of interleukin-1 receptor-associated kinase
WO2017205762A1
Inhibitors of interleukin-1 receptor-associated kinase
WO2017205766A1
Inhibitors of interleukin-1 receptor-associated kinase
WO2017087947A2
Method of treatment of follicular lymphoma with a btk inhibitor
WO2017053823A1
Treatment using hdac inhibitors and immunotherapy
CA2996177A1
Btk inhibitor combinations for treating multiple myeloma
CN108024996A
Bruton's tyrosine kinase inhibitor combines and its purposes
EP3310776A2
Inhibitors of bruton's tyrosine kinase
PH12016500743A1
Treatment using bruton`s tyrosine kinase inhibitors and immunotherapy
WO2016161347A1
Combinations for generating tumor-specific immunological memory
WO2016161054A1
Massive parallel primer dimer-mediated multiplexed single cell-based amplification for concurrent evaluation of multiple target sequences in complex cell mixtures
EP3273961A1
Solvated forms of a bruton's tyrosine kinase inhibitor
CN107530347A
The co-crystal thereof of bruton's tyrosine kinase inhibitor
CN107427498A
The medical formulation of bruton's tyrosine kinase inhibitor
WO2016123504A1
Btk inhibitor combinations and multidrug-resistance
CN107108640A
The synthesis of bruton's tyrosine kinase inhibitor
AU2015275321A1
The use of inhibitors of Bruton's tyrosine kinase (Btk)
CN107106565A
BTK inhibitor is combined and dosage regimen
WO2016100593A1
Methods and assays for quantification and normalization of kinase and ligand binding
